期刊文献+

小鼠端粒酶蛋白亚单位转染树突状细胞体外诱导特异性抗肝癌细胞免疫应答

Induction of specific CTL elicited by dendritic cells transfected with recombinant adenovirus vector expressing the mouse telomerase reverse transcriptase in vitro
原文传递
导出
摘要 目的观察携带小鼠端粒酶蛋白亚单位(mTERT)基因重组腺病毒载体(AdmTERT)转染树突状细胞(DC)后诱发免疫效应细胞产生特异性抗肝癌细胞免疫应答的研究。方法用流式细胞仪分析及电镜观察培养6dDC的细胞表型及形态,Ad—mTERT重组腺病毒转染体外培养的小鼠DC,Western blot检测mTERT融合蛋白表达;用负载mTERT的DC刺激同型淋巴细胞,免疫磁珠分选CD8^+T细胞做为效应细胞,小鼠肝癌细胞株(H22)及小鼠结肠癌细胞(CT26)作为靶细胞,用酶联免疫吸附试验(ELISA)及酶联免疫斑点法(ELISPOT)检测干扰素(IFN)-γ分泌量和释放抗原特异性IFN-γ的T细胞数,^51Cr释放法检测细胞毒性T淋巴细胞(CTL)对肝癌细胞的杀伤活性。结果细胞表型及形态观察证实小鼠骨髓来源的DC为成熟的树突状细胞;AdmTERT转染DC后能正确表达mTERT融合蛋白,用AdmTERT转染DC致敏的淋巴细胞IFN-γ分泌量(208.6μg/L)和分泌IFN—γ的特异性T细胞的数量(341/10^6脾细胞)都高于Ad—GFP转染的DC组(14.2μg/L,33/10^6脾细胞)和单纯DC组(12.1μg/L,19/10^6脾细胞,P〈0.05)。AdmTERT修饰DC刺激产生的效应T细胞在效靶比为90:1时,对H22细胞的杀伤率(54.2%)明显高于AdGFP致敏组(8.2%)和未致敏DC组(4.5%,P〈0.05),而对CT26细胞无明显杀伤作用。结论AdmTERT修饰的DC体外能够诱导出针对mTERT抗原特异性的CTL效应.可特异性杀伤mTERT阳性的肝癌细胞。 Objective To investigate the mouse telomerase reverse transcriptase (mTERT) specific CTL elicited by dendritic cells (DC) transfected with adenovirus vector expressing the mouse telomerase reverse transcriptase (AdmTERT) and its anti-tumor effect in vitro. Methods Flow cytometry and electron microscopy were used to observe DC phenotype and morphology. DC were transfeeted with AdmTERT. T cells were isolated from mouse spleen. After third stimulation, eytotoxicity of mTERT specific CTL was determined by using 51 Cr release assay. H22 and CT26 cells were used as stimulators, and CD8^ + T cells as responders. IFN-γ/positive blots were developed and calculated following the kit' s instruction. IFN-γ ELISPOT assays for antigen specific IFN-γ production by T cells. Results Phenotype and morphous observe mouse bone marrow from DC was full-blown and express mTERT fusion protein. IFN-γ/secreted (208.6 μg/L) and IFN-γ secreting cells (341/106 spleen cell)elicited by the AdmTERT infected DCs were much stronger and higher than that by Ad-GFP group (14.2 μg/L,33/106 spleen cell)and DC group (12.1 μg/L, 19/106 spleen cell). High cytotoxicity of mTERT specific CTL could be elicited by AdmTERT transfected DC groups ( 54.2% ) , in comparison, no specific lysis was observed for T cells coeultured with control groups. Conclusion DC transfeeted with adenovirus encoding mTERT can induce strong and functional mTERT antigen specific CTL and remarkable anti-tumor effect in vitro.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2009年第10期1319-1321,共3页 Chinese Journal of Experimental Surgery
基金 国家重点基础研究发展计划(973计划)资助项目(2009CB522404) 国家十一五科技重大专项(2008ZX10002-026) 广东省科技计划项目重大专项(2007A032000001) 2007-2009年度卫生部部属(管)医院临床学科重点资助项目
关键词 肝细胞 树突状细胞 端粒酶 细胞毒T淋巴细胞 Carcinoma,hepatoeellular Dendritic cell Telomerase Cytotoxieity T lymphocyte
  • 相关文献

参考文献6

二级参考文献17

  • 1VONDERHEIDE R H,HAHN W C,SCHULTZE J L,et al.The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes[J].Immunity,1999,10(6):673-679.
  • 2ALDEN T D,PHTMAN D D,BERES E J,et al.Percutaneous spinal fusion using bone morphogenetie protein gene therapy[J].J Neurosurg,1999,90(1 Suppl):109-114.
  • 3LATTERMANN C,OXNER WM,XIAO X,et al.The adeno associated viral vector as a strategy for intradiscal gene transfer in immune competent and pre-exposed rabbits[J].Spine,2005,30(5):497-504.
  • 4POOLE J C,ANDREWS L G,TOLLEFSBOL T O.Activity,function,and gene regulation of the catalytic subunit of telomerase(hTERT)[J].Gene,2001,269(1-2):1-12.
  • 5DUCREST A L,SZUTORISZ H,LINGNER J,et al.Regulation of the human telomerase reverse transcriptase gene[J].Oncogene,2002,21(4):541-552.
  • 6HARLEY C B.Telomerase is not an oncogene[J].Oncogene,2002,21(4):494-502.
  • 7DOYLE L A,HIGHSMITH W E.Telomerase as a diagnostic and therapeutic target for cancer[J].Expert Rev Anticancer Ther,2002,2(2):217-225.
  • 8TAKEUCHI H,KANZAWA T,KONDO Y,et al.Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells[J].Int J Oncol,2004,25(1):57-63.
  • 9Gallucci M, Guadagni F, Marzano R, et al. Status of the p53, p16, RB1,and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters. J Clin Pathol, 2005, 58 : 367-371.
  • 10Hitchings AW, Kumar M, Jordan S, et al. Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb. Br J Cancer,2004, 91 : 552-557.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部